Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

June 25, 2020

Whole-genome sequencing analysis of multidrug-resistant Mycobacterium tuberculosis from Java, Indonesia

Journal of Medical Microbiology
Tryna TaniaKiatichai Faksri
June 26, 2020

A bioinorganic chemistry perspective on the roles of metals as drugs and targets against Mycobacterium tuberculosis - a journey of opportunities

Dalton Transactions : an International Journal of Inorganic Chemistry
Luiz G F LopesEduardo H S Sousa
July 14, 2020
Review
Open Access

Indian National Association for the Study of the Liver Consensus Statement on Acute Liver Failure (Part 1): Epidemiology, Pathogenesis, Presentation and Prognosis

Journal of Clinical and Experimental Hepatology
Anil C AnandINASL Task-Force on Acute Liver Failure
July 2, 2020
Open Access

Incidence of Tuberculosis During the First Year of Antiretroviral Treatment in West African HIV-Infected Adults

Open Forum Infectious Diseases
Boris Tchakounte YounguiOlivier Marcy
July 1, 2020
Open Access

Isoniazid-Resistant Tuberculosis of the Parotid Gland Masquerading as a Benign Neoplasm

Ear, Nose, & Throat Journal
Subin LeeTodd E Falcone
July 12, 2020

In Vitro Antimycobacterial Activity and Physicochemical Characterization of Diaryl Ether Triclosan Analogues as Potential InhA Reductase Inhibitors

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Tarek S IbrahimAmany M M Al-Mahmoudy
July 9, 2020

Population pharmacokinetics of isoniazid and dose recommendations in Mexican patients with tuberculosis

International Journal of Clinical Pharmacy
Ana Patricia Huerta-GarcíaRosa Del Carmen Milán-Segovia
July 13, 2020
Review

Identifying isoniazid resistance markers to guide inclusion of high-dose isoniazid in tuberculosis treatment regimens: a systematic review

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
Emmanuel RivièreAnnelies Van Rie
June 26, 2020

Model-Based Cost-Effectiveness of State-level Latent Tuberculosis Interventions in California, Florida, New York and Texas

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Youngji JoDavid Dowdy
July 1, 2020

Trichloro(dinitrogen)platinate(II)

Chemistry : a European Journal
Gilian T ThomasJason Scott McIndoe
July 7, 2020
Open Access

Study on Genotyping Polymorphism and Sequencing of N-Acetyltransferase 2 (NAT2) among Al-Ahsa Population

BioMed Research International
Mohammad Abu ZahraAbdulla Al-Taher
July 8, 2020

First-line anti-tubercutilosis drugs-loaded starch nanocrystals for combating the threat of M. tuberculosis H37Rv strain

Carbohydrate Research
Shivang K DesaiSmritilekha Bera
July 3, 2020
Open Access

Antimycobacterial Effects of Everolimus in a Human Granuloma Model

Journal of Clinical Medicine
David AshleyVishwanath Venketaraman

Sign up to follow this feed and discover related papers.

Related Feeds

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Anthelmintics (ASM)

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Ascariasis (ASM)

Ascariasis is a helminthic infection of global distribution with more than 1.4 billion persons infected throughout the world. Here is the latest research.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Bacterial Cell Wall Structure (ASM)

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

© 2020 Meta ULC. All rights reserved
/feed-previews/antitubercular-agents-asm/3836da9d-42d6-47b8-b90f-bd185134b3eb